News and reflections from the world of AI

Epredia and Aiforia announce partnership for global distribution of AI-powered pathology software

Portsmouth, NH, USA, June 21, 2021 – Epredia, a global leader in precision cancer diagnostics, and Aiforia, a medical software company providing Artificial Intelligence (AI) based solutions for image analysis in pathology, have announced today that they have entered into a commercial distribution agreement for Aiforia’s comprehensive portfolio of workflow enhancing solutions which enable ...

Aiforia announces CE-IVD mark for AI-supported breast cancer diagnostics

First-of-its kind diagnostic tool Aiforia today announced the CE-IVD Mark for the Aiforia® Clinical AI Model for Breast Cancer; Ki67, a widely used key biomarker in breast cancer diagnostics across pathology labs around the world. The AI Model is able to calculate Ki67 positive and negative cells in invasive areas of human breast tissue in whole slide images (WSI) as well as in specific areas — ...

Aiforia Raises €12.6M in Series B Funding to Enhance Precision Diagnostics and Preclinical Analysis in Pathology

Helsinki – June 3, 2021 - Aiforia, a software company providing AI-based solutions for clinical and preclinical image analysis in pathology, announced today the closing of the first €12.6M tranche of their Series B round. The funding round has the potential to reach €25.2M if investors exercise the optional second tranche. The funding round is led by Epredia's UK entity, a subsidiary of PHC ...

New Finnish consortium aims to enhance diagnostics and combat pandemics

The COVID-19 pandemic has highlighted the importance of efficient diagnostic methods. Beyond battling pandemics, there are also significant diagnostic needs in everyday healthcare but healthcare systems around the world are struggling with rapidly increasing costs. The Future of Diagnostics (FUDIS) co-innovation consortium was created to address these challenges — to develop reliable, rapid, ...

Aiforia appoints Swedbank as lead advisor to explore financing options

Aiforia Technologies Oy ("Aiforia" or "the Company") has appointed Swedbank AB (publ) as their lead financial advisor to explore different financing options, including possibilities for an Initial Public Offering (IPO) by listing the Company's shares on Nasdaq Helsinki First North.

DECIDER project launches to improve diagnostics and treatment of ovarian cancer

The European Union has funded a project to improve personalized treatments for ovarian cancer with nearly 15 million euros for five years. The international DECIDER project has partners from 14 organizations in seven EU countries.